Adaptimmune Competitors and Similar CompaniesClear all

Adaptimmune's competitors and similar companies include Bellicum Pharmaceuticals, PolyPid, Metabolon and VBI Vaccines.
Adaptimmune
Adaptimmune
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
PolyPid
PolyPid
PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).
Metabolon
Metabolon
Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.
VBI Vaccines
VBI Vaccines
VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
Founding Date
Founding Date
2008
Founding Date
2004
Founding Date
2008
Founding Date
2000
Founding Date
2001
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Philadelphia, US HQ
Milton, GB
Milton, GB
Stevenage, GB
Locations
Houston, US HQ
Houston, US
Houston, US
South San Francisco, US
Locations
Petah Tikva, IL HQ
Summit, US
Locations
Morrisville, US HQ
Hallbergmoos, DE
München, DE
Locations
Cambridge, US HQ
Ottawa, CA
Rehovot, IL
Employees
Employees
4007% decrease
Employees
1386% increase
Employees
6510% increase
Employees
262
Employees
12314% increase
Valuation ($)
Valuation ($)
162.4 m
Valuation ($)
778.3 k
Valuation ($)
22.3 m
Valuation ($)
N/A
Valuation ($)
18.6 m
Twitter followers
Twitter followers
3.8 k
Twitter followers
588
Twitter followers
N/A
Twitter followers
2.8 k
Twitter followers
2.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
8.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
55.56%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
$60.3m (FY, 2023)
Revenue (est.)
$1.5m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$8.7m (FY, 2023)
Net income
Net income
($113.9m) (FY, 2023)
Net income
($25m) (FY, 2022)
Net income
($23.9m) (FY, 2023)
Net income
N/A
Net income
($92.8m) (FY, 2023)

Operating

Patent Applications
Patent Applications
69 (FY, 2016)
Patent Applications
N/A
Patent Applications
49 (FY, 2017)
Patent Applications
N/A
Patent Applications
N/A
Patents Issued
Patents Issued
173 (FY, 2016)
Patents Issued
N/A
Patents Issued
104 (FY, 2017)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 107.5m
Total funding raised
N/A
Total funding raised
$ 103.8m
Total funding raised
$ 95.4m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Bellicum Pharmaceuticals
HQ
Houston, US
Employees
13

Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.

View company
PolyPid
HQ
Petah Tikva, IL
Employees
65↑ 10% increase

PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).

View company
Metabolon
HQ
Morrisville, US
Employees
262

Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.

View company
VBI Vaccines
HQ
Cambridge, US
Employees
123↑ 14% increase

VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.

View company